Designed for contrast media injections, the PowrSyringe is capable of an injection that is between 20 and 100% faster than a standard control syringe. Nothing beats the need for speed when it comes to ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the United States, starting immediately with the launch of ...

The report Contrast Media Injectors Market size is estimated to be USD 1.3 billion in 2020 and projected to reach USD 1.9 billion by 2025, at a CAGR of 7.4%. Factors such as the growing prevalence of ...

Due to COVID-19 related supply-chain disruptions, Iodixanol and other contrast media agents have been in shortage nationwide. Fresenius Kabi announced the launch of Iodixanol Injection, a generic ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. 53% of patients with an iodinated contrast allergy and ...

CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...

To address the ongoing COVID-19 related iodinated contrast media product shortage, Iomeron will be temporarily available in the US starting at the end of August 2022. To address the ongoing COVID-19 ...

Elucirem™, a Novel New Macrocyclic GBCA for Use in Contrast-Enhanced Magnetic Resonance Imaging (MRI), has the highest relaxivity compared to other non-specific GBCAs (gadolinium-based contrast agents ...

CHICAGO, Sept. 2, 2020 /PRNewswire/ -- According to the new market research report "Contrast Media Injectors Market By Product (Injector Systems (CT Injector, MRI Injector), Consumables (Syringes), ...

CHICAGO, Sept. 18, 2019 /PRNewswire/ -- According to the new market research report "Contrast Media Injectors Market by Product (Injector Systems (CT Injector, MRI Injector), Consumables (Injector ...